Covid-19 – Page 5 – Go Retire Psychiatrist

CDC ACIP Meeting February 28-29, 2024 to Discuss Covid-19 and Other Vaccines

There are news stories about a pending CDC-ACIP meeting (February 28-29, 2024) which might include information about a CDC recommendation to possibly add a 3rd additional Covid-19 vaccine booster this spring.

The Covid-19 vaccine portion of the meeting is scheduled for February 28, 2024 at 8:30 AM EST. There will be a vote at 1:55 PM EST that day.

Interestingly, also on the agenda is a discussion about the RSV vaccine on February 29, 2024 at 8:30 AM EST. We wonder whether the committee will talk about the current requirement for a shared clinical-decision making discussion with a physician for getting the RSV vaccine.

New Large Covid-19 Vaccine Study Shows Association with Rare Side Effects Which Other Smaller Studies Have Found

I’ve seen a couple of news stories about the CDC supported large study across many countries which essentially shows that Covid-19 vaccines can be associated with rare side effects. The stories might tend to raise anxiety about the vaccines’ overall safety, which has been repeatedly proven in other studies.

The study is published in the journal Vaccine and the conclusions are consistent with smaller studies showing the Covid-19 vaccines safety although they do have rare side effects.

One of the news stories contacted an expert, Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center, who confirmed that.

Unfortunately, there are over 1200 comments (and counting) containing alarmist and misleading information about the vaccines.

CDC May Change the 5 Day Covid-19 Isolation Guidelines

I see many news headlines reporting that the CDC may be planning to drop the 5 day Covid-19 isolation guidelines. For now I’m taking that as a rumor until the CDC website says something official about it.

Word on the street is that we may know more in April.

CDC Reports Decreasing Respiratory Virus Activity

How about some good news? The CDC Respiratory Virus Data Channel reports decreasing respiratory virus activity as of January 26, 2024.

CDC Reports Respiratory Virus Activity Elevated or Increasing

The CDC on January 12, 2024 reported that respiratory virus activity is elevated or increasing across the country. The summary:

“Summary

Seasonal influenza and COVID-19 activity remain elevated in most parts of the country; however, the rapid increases seen over the past several weeks appear to be slowing. The U.S. continues to experience elevated RSV activity, particularly among young children. Hospital bed occupancy for all patients, including within intensive care units, remains stable nationally. However, some jurisdictions are reporting strain on hospitals locally, driven, in part, by recent increases in respiratory illness.

Influenza

Multiple indicators of influenza activity including test positivity, emergency department visits, and hospitalizations are elevated. Additional information about the recent increases in influenza activity can be found at: Weekly U.S. Influenza Surveillance Report | CDC.

COVID-19

Despite test positivity (percentage of tests conducted that were positive), emergency department visits, and hospitalizations remaining elevated nationally, the rates have stabilized, or in some instances decreased, after multiple weeks of continual increase. Emergency department visits for COVID-19 are highest among infants and older adults but are also elevated for young children. Despite the high levels of infection measured using wastewater viral activity and test positivity data, at this time, COVID-19 infections are causing severe disease less frequently than earlier in the pandemic.

RSV

RSV activity remains elevated nationally in all regions, though decreases have been observed in some areas. Hospitalization rates remain elevated in young children and continue to increase among older adults.

Vaccination

National vaccination coverage for COVID-19, influenza, and RSV vaccines remains low for children and adults. Vaccines are available and can help protect people from the most serious health effects of fall and winter viruses.”

CDC Weekly Snapshot Shows Respiratory Virus Activity High

As of January 5, 2024, CDC is reporting that respiratory illness is increasing across the country. The levels are generally high in almost all regions.

“Activity Levels Update:

The amount of respiratory illness (fever plus cough or sore throat) causing people to seek healthcare is elevated or increasing across most areas of the country. This week, 39 jurisdictions experienced high or very high activity.
Nationally, emergency department visits due to influenza and COVID-19 are elevated in all age groups and increasing in all but school-aged children. Recent, holiday-related school closures and associated changes in healthcare seeking behavior may be impacting trends in influenza- and COVID-19-related visits among school-aged children. RSV-related emergency department visits decreased slightly nationally.
Nationally, COVID-19 wastewater viral activity levels and test percent positivity—indicators for infection levels—are higher than the same time last year (currently estimated as being 27% higher and 17% higher, respectively). However, indicators for illness requiring medical attention are lower, including emergency department rates being 21% lower than the same time last year.”

CDC Reports Respiratory Virus Activity Increasing

The Centers for Disease Control (CDC) reported respiratory illness leading to visits to the emergency room and hospitalization are rising across the country.

“Seasonal influenza activity is elevated and increasing in most parts of the country.
COVID-19 activity also remains elevated overall and is increasing in many areas.  Based on the biweekly period ending 12/23/2023, JN.1 is predicted to be the most prevalent SARS-CoV-2 lineage nationally.
RSV activity remains elevated in many areas of the country, though decreases have been observed in some areas.
Hospital bed occupancy and capacity, including within intensive care units, remain stable nationally.”

“National test positivity, emergency department visits, and hospitalizations for influenza continue to increase. Influenza A(H1N1) is the predominant influenza virus circulating although influenza A(H3N2) and influenza B viruses are also being reported.
RSV-associated hospitalization rates remain elevated among young children and are increasing among older adults; of note, only 15.9% of adults 60+ report having received an RSV vaccine.
National vaccination coverage for COVID-19, influenza, and RSV vaccines increased slightly for children and adults compared to the previous week and remains low for both groups.”

However, the overall respiratory illness rates have gone from “moderate” to “low” in Iowa.